Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

CapsoVision, Inc (CV) Profit Margins

Over the twelve months to 2026-06-30, CapsoVision, Inc (CV) had gross margin 50.9%, operating margin -217.1%, net margin -214.7%, free cash flow margin -200.8%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CVCapsoVision, IncFollow CV — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
349.8M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days
LineFY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin54.2%52.9%50.9%
Operating margin-169.4%-188.3%-217.1%
Net margin-169.3%-186.8%-214.7%
FCF margin-172.2%-169.4%-200.8%

USD millions · SEC XBRL

CapsoVision, Inc — questions

What is CapsoVision, Inc's gross margin?
50.9% over the twelve months to 2026-06-30.
What is CapsoVision, Inc's operating margin?
-217.1% over the twelve months to 2026-06-30.
What is CapsoVision, Inc's net profit margin?
-214.7% over the twelve months to 2026-06-30.

Every figure on this page comes from CapsoVision, Inc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.